You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

688 Results
Guidelines and Advice
Status: Current
ID: GL 5-3ORG
Version: 2
Apr 2019
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab Emtansine - Adjuvant Treatment for Early Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
Kadcyla trastuzumab emtansine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Oct 2023
Document
May 2019
Document
May 2019
Blog post
A quick glance at cancer statistics can be quite sobering: Nearly one out of every two people in Ontario will develop cancer in their lifetime, and...
Jun 2019
Document
Jun 2019
Document
Jun 2019
Document
Jun 2019
Document
Jun 2019
Document
Jun 2019
Document
Jul 2019
Document
Jul 2019

Pages